The Blocking Solution Cat. No. #110

Ready-to-use; Casein based blocker. The most effective Blocker from CANDOR contains standardised and stabilised casein fragments as active blockers. Saturates free binding sites on plastic surfaces, membranes or other protein binding surfaces and thereby reducing high background in immunoassays.
£112.58

Choose your options

The Blocking Solution for ELISA, EIA, RIA, protein arrays, Western blotting, immuno-PCR and immunohistochemistry.

The most effective Blocker from CANDOR Bioscience

The Blocking Solution saturates free binding sites on plastic surfaces, membranes or other protein binding surfaces. The Blocking Solution prevents non-specific binding to surfaces.

By incubating the surface with The Blocking Solution (e.g. microtiter plate or western blotting membrane), free spaces on the surface are saturated by the components of The Blocking Solution. This minimizes unwanted binding of the analyte or the detection antibody to the surface and so background can be avoided and sensitivity of the assay can be improved.

The Blocking Solution is based on chemically modified and defined fragments of highly purified casein.

The Blocking Solution is not comparable to other commercially available or lab-made casein based solutions which are produced by just dissolving and filtrating of casein.

Benefits of The Blocking Solution

Generally speaking, the blocking effectiveness depends on different factors. The more effective the blocker, the more reliable are the results of the assays (even with different specimens). It is important to achieve complete saturation of the surface without any gaps. There should be no exchange reaction between molecules of the blocking layer and the sample matrix. In addition any interaction of molecules in the blocking layer with the sample matrix should also be prevented. A good blocker can fill even very small gaps and can minimize such interactions.

The Blocking Solution is the premium product of a new class of blockers developed by CANDOR Bioscience. These blockers carry chemical modifications which help to minimize interactions between the blocking layer and the sample matrix.

The Blocking Solution is based on highly purified casein which has been chemically modified. In addition the casein molecules were fragmented in an advanced production process. The specific procedure during fragmentation of the casein molecules results in a wide spectrum of variably sized casein fragments – reproducible from batch to batch.

Due to the variably sized casein fragments, the adsorption efficiency of classic protein-based blockers is combined with a blocking layer of small molecules and maximal density. The mixture of variably sized molecules ensures an extremely dense packing structure of the adsorptive blocking layer.

The chemical modification preserves these structures during the assay and minimizes the tendency to interactions. These advantages can be used without changing the blocking procedure. In many assays a reduction of incubation time for blocking can be realized by using The Blocking Solution.

The Blocking Solution is recommended for assays which require high reproducibility and low coefficients of variation. Examples are assays in medical and pharmaceutical research such as assays for pre-clinical and clinical studies, production of high quality diagnostics or measurement of precious specimens.

For research use only, not for diagnostic use.

Please note that the 1 L size will be packaged in 2x 500 ml bottles.
 


Download Product Resources

Product Descriptions & Guides
Product Inserts and Data Sheets

Brand CANDOR Bioscience
Code 110 125

Product Flyers and Application Guides

 BIOAXXESS CANDOR Blocker Selection Guide NEW
BIOAXXESS CANDOR Product Application Guide
 CANDOR Products Brochure
 Assay Defender® Flyer NEW
 Assay Defender® Use NEW
 Assay Defender® LowCross-Buffer® Comparison Matrix NEW
 SafetyTector™ S NEW
 


Product Inserts and Data Sheets

Assay Optimizers

 Assay Defender® Cat. No. #180  NEW
 LowCross-Buffer® Cat. No. #100, #101, #102
 LowCross-Buffer® Animal-free/Protein-free Cat. No. #300, #301, #302
 Low-Cross-HRP® Cat. No. #200
 LowCross® HRP-Stab Cat. No. #270
 LowCross® HRP-Stab Animal-free/Protein-free Cat. No. #370
 Sample Buffer Cat. No. #105, #106
 Sample Buffer Animal-free/Protein-free Cat. No. #305


Covid-19 Inactivation and Dilution Buffer

 SafetyTector™ S Cat. No. #400  NEW
 

Blockers

 The Blocking Solution Cat. No. #110
 BSA-Block Cat. No. #115
 PlateBlock™ Cat. No. #112  NEW  
 SmartBlock™ Cat. No. #113


Stabilizers

 Antibody Stabilizer TRIS Cat. No. #130
 Antibody Stabilizer TRIS Animal-free/Protein-free Cat. No. #330
 Antibody Stabilizer PBS Cat. No. #131
 Antibody Stabilizer PBS Animal-free/Protein-free Cat. No. #331
 AP-Protector® Cat. No. #235
 Liquid Plate Sealer® Cat. No. #160
 Liquid Plate Sealer® Animal-free Cat. No. #163
 HRP-Protector™ Cat. No. #222
 HRP-Protector™ Animal-free/Protein-free Cat. No. #322


Standard Buffers (ready-made)

 Coating Buffer pH 7.4 Cat. No. #120
 Coating Buffer pH 9.6 Cat. No. #121
 Stripping Buffer Cat. No. #150
 Washing Buffer PBS Cat. No. #140
 Washing Buffer PBS IHC Cat. No. #141
 Washing Buffer TRIS Cat. No. #145
 Washing Buffer TRIS IHC Cat. No. #146


All-in-One Western Blotting Solution

 ReadyTector® Cat. No. #720 and 730


Tool boxes

 Blocking Sampler Package with BSA Block Cat. No. #600
 CANDOR Starter Package Cat. No. #600
 CANDOR Starter Package IHC Cat. No. #600


Publications

 CoViD-19-antibody-test-challenge
 Interference and HAMA problems
 IVD Technology Article
 Long-term stabilization of assay components
 Optimisation of assays: Interference in immunoassays recognize and avoid 
 SARS-CoV-2 antigen tests: safety for less than 5 cents per test 
 Specificity, positive predictive value and validation statistics in the context of CoViD-19
 The Appropriate Blocker — A Short Overview
 The right strategy saves much costs